Journal of Preventive Medicine and Public Health

  • 제46권6호
  • /
  • Pages.293-299
  • /
  • 2013
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지
DOI QR코드

DOI QR Code

The Economic Burden of Epilepsy in Korea, 2010

  • Jung, Jaehun (Department of Preventive Medicine, Korea University College of Medicine) ;
  • Seo, Hye-Young (Graduate School of Public Health, Korea University) ;
  • Kim, Young Ae (Graduate School of Public Health, Korea University) ;
  • Oh, In-Hwan (Department of Preventive Medicine, Kyung Hee University College of Medicine) ;
  • Lee, Yo Han (Department of Preventive Medicine, Korea University College of Medicine) ;
  • Yoon, Seok-Jun (Department of Preventive Medicine, Korea University College of Medicine)
  • 투고 : 2013.04.15
  • 심사 : 2013.09.16
  • 발행 : 2013.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010. Methods: This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs. Results: The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy. Conclusions: A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.

키워드

참고문헌

  1. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46(4): 470-472. https://doi.org/10.1111/j.0013-9580.2005.66104.x
  2. Sridharan R. Epidemiology of epilepsy. Curr Sci 2002;82(6): 664-670.
  3. De Boer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy Behav 2008;12(4):540-546. https://doi.org/10.1016/j.yebeh.2007.12.019
  4. Banerjee PN, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy-a review. Epilepsy Res 2009;85(1):31-45. https://doi.org/10.1016/j.eplepsyres.2009.03.003
  5. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003;16(2):165-170. https://doi.org/10.1097/00019052-200304000-00008
  6. Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004;110(4):207-220. https://doi.org/10.1111/j.1600-0404.2004.00324.x
  7. Yoon D, Frick KD, Carr DA, Austin JK. Economic impact of epilepsy in the United States. Epilepsia 2009;50(10):2186-2191. https://doi.org/10.1111/j.1528-1167.2009.02159.x
  8. Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P. Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 2007;48(12):2224-2233.
  9. Lee SY, Jung KY, Lee IK, Yi SD, Cho YW, Kim DW, et al. Prevalence of treated epilepsy in Korea based on national health insurance data. J Korean Med Sci 2012;27(3):285-290.
  10. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349(9063):1436-1442. https://doi.org/10.1016/S0140-6736(96)07495-8
  11. Stat NC. Healthy people 2000 review, 1995-1996. Hyattsville: Public Health Service; 1996, p. 1-3.
  12. Park JM, Tae YH. Results of survey on medical care cost by patient in Survey on the Benefit Coverage Rate of National Health Insurance in 2010. Seoul: National Health Insurance Corporation; 2011, p. 136-138.
  13. Korea Health Panel. The Korea Health Panel Survey [cited 2011 Aug 18]. Available from: http://www.khp.re.kr/english/about_01.jsp.
  14. Korean Guardian Association. The official averaged guardian cost. Seoul: Korean Guardian Association; 2008, p. 3-5.
  15. Ministry of Employment and Labor. 2008 The survey report on labor conditions by employment type [cited 2012 Aug 18]. Available from: http://laborstat.molab.go.kr/newWeb/intro/sub1/sub01_02.jsp.
  16. Korea National Statistical Office. Korean Statistical System 2010 [cited 2012 Aug 18]. Available from: http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=A.
  17. World Health Organization. ICD-10: international statistical classification of diseases and related health problems [cited 2012 May 5]. Available from: http://apps.who.int/classifications/icd10/browse/2010/en.
  18. Jeong YH, Ko SJ. An estimation of economic costs of 5 major diseases. Health Welf Policy Forum 2003;79:55-65.
  19. Engel J Jr; International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42(6):796-803. https://doi.org/10.1046/j.1528-1157.2001.10401.x
  20. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991;32(4):429-445. https://doi.org/10.1111/j.1528-1157.1991.tb04675.x
  21. Forsgren L. Prevalence of epilepsy in adults in northern Sweden. Epilepsia 1992;33(3):450-458. https://doi.org/10.1111/j.1528-1157.1992.tb01690.x
  22. Forsgren L, Beghi E, Oun A, Sillanpää M. The epidemiology of epilepsy in Europe: a systematic review. Eur J Neurol 2005; 12(4):245-253. https://doi.org/10.1111/j.1468-1331.2004.00992.x
  23. Trinka E, Höfler J, Zerbs A. Causes of status epilepticus. Epilepsia 2012;53 Suppl 4:127-138. https://doi.org/10.1111/j.1528-1167.2012.03622.x
  24. Vezzani A, Balosso S, Ravizza T. Inflammation and epilepsy. Handb Clin Neurol 2012;107:163-175. https://doi.org/10.1016/B978-0-444-52898-8.00010-0
  25. Besocke AG, Rosso B, Cristiano E, Valiensi SM, García Mdel C, Gonorazky SE, et al. Outcome of newly-diagnosed epilepsy in older patients. Epilepsy Behav 2013;27(1):29-35. https://doi.org/10.1016/j.yebeh.2012.11.041
  26. Kim HJ, Kim YA, Seo HY, Kim EJ, Yoon SJ, Oh IH. The economic burden of stroke in 2010 in Korea. J Korean Med Assoc 2012; 55(12):1226-1236. https://doi.org/10.5124/jkma.2012.55.12.1226
  27. Lee YH, Yoon SJ, Kim EJ, Kim YA, Seo HY, Oh IH. Economic burden of asthma in Korea. Allergy Asthma Proc 2011;32(6):35-40. https://doi.org/10.2500/aap.2011.32.3479
  28. Kim SY, Yoon SJ, Jo MW, Kim EJ, Kim HJ, Oh IH. Economic burden of allergic rhinitis in Korea. Am J Rhinol Allergy 2010; 24(5):e110-e113.
  29. Strzelczyk A, Reese JP, Dodel R, Hamer HM. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008;26(6):463-476. https://doi.org/10.2165/00019053-200826060-00002
  30. King JT Jr, Sperling MR, Justice AC, O'Connor MJ. A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy. J Neurosurg 1997;87(1):20-28. https://doi.org/10.3171/jns.1997.87.1.0020
  31. Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, et al. Health care costs decline after successful epilepsy surgery. Neurology 2007;68(16):1290-1298. https://doi.org/10.1212/01.wnl.0000259550.87773.3d

피인용 문헌

  1. The Economic Burden of Hepatitis A, B, and C in South Korea vol.69, pp.1, 2013, https://doi.org/10.7883/yoken.jjid.2014.499
  2. Costs of informal nursing care for patients with neurologic disorders : A systematic review vol.90, pp.1, 2013, https://doi.org/10.1212/wnl.0000000000004763
  3. The Present and Future of Vagus Nerve Stimulation vol.62, pp.3, 2019, https://doi.org/10.3340/jkns.2019.0037
  4. Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia vol.14, pp.None, 2013, https://doi.org/10.2147/rmhp.s289113
  5. Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea vol.126, pp.None, 2022, https://doi.org/10.1016/j.yebeh.2021.108459